NEU 3.50% $14.05 neuren pharmaceuticals limited

ROW Rights, page-67

  1. 3,450 Posts.
    lightbulb Created with Sketch. 820
    This is the best partnership and result for Neuren, and for Acadia. I previously posted that Acadia would want to expand their business development and presence across the globe and this expansion with Neuren certainly achieves this aim.

    Next milestone in the next 2 years will possibly see a full takeover by Acadia. Fine by me. Well done Jon Pilcher and the entire team.

    GLTAH, it’s time to sit back and watch this wonderful investment story by an Australian company unfold as patients live’s are changed right around the world.
    Last edited by sarge17: 14/07/23
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.